FDA considers adding a dozen peptides to its bulk drug compounding list RAPS When will the FDA reclassify BPC 157 to Category 1 Octagon AI The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York